Regarding, in particular, the impact of CLDN16 mutations on protein function, a genotype/phenotype correlation has been proposed reflecting the severity of FHHNC [3]. The gene discussed is CLDN16; the disease is familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis.